Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Airborne particle detection in pharmaceutical workshops is a critical cleanroom verification activity used to classify and monitor air cleanliness in sterile and non-sterile drug manufacturing environments. Performed in accordance with ISO 14644-1, EU GMP Annex 1, and GB/T 25915, this testing demonstrates that non-viable particle concentrations remain within regulatory limits, protecting product quality and patient safety. This article explains the testing principles, sampling procedures, acceptance criteria, and practical applications of suspended particle detection in pharmaceutical production facilities.

Technical Overview

Airborne (suspended) particle detection measures the concentration of non-viable particles in the air of pharmaceutical cleanrooms, clean zones, restricted access barrier systems (RABS), and isolators. Because airborne particulates can carry microorganisms and contaminate products—especially sterile injectables, ophthalmic preparations, and biologics—regulatory authorities worldwide require documented evidence that particle concentrations are controlled within defined limits.

The core regulatory and technical framework for this testing includes:

  • ISO 14644-1 (Cleanrooms and associated controlled environments — Part 1: Classification of air cleanliness by particle concentration)
  • ISO 14644-2 (Monitoring to provide evidence of cleanroom performance related to air cleanliness by particle concentration)
  • ISO 21501-4 (Calibration of light scattering airborne particle counters)
  • EU GMP Annex 1 (Manufacture of Sterile Medicinal Products), which defines Grades A, B, C, and D
  • FDA Aseptic Processing Guidance and cGMP requirements
  • GB/T 25915 (the Chinese national adoption of ISO 14644) and GB 50457 (Code for design of pharmaceutical cleanrooms)

Cleanliness Classes and Particle Limits

ISO 14644-1 classifies cleanrooms from ISO Class 1 (cleanest) to ISO Class 9 based on particle concentration per cubic meter at specified particle sizes. For pharmaceutical applications, the most commonly referenced threshold sizes are 0.5 μm and 5.0 μm. Typical limits at ≥0.5 μm include:

  • ISO Class 5 (equivalent to EU GMP Grade A/B at rest): 3,520 particles/m³
  • ISO Class 6: 35,200 particles/m³
  • ISO Class 7 (typical Grade C at rest): 352,000 particles/m³
  • ISO Class 8 (typical Grade D at rest): 3,520,000 particles/m³

EU GMP Annex 1 additionally imposes a limit of 20 particles/m³ at ≥5.0 μm for Grade A zones, reflecting the strong correlation between larger particles and microbial contamination risk.

Static Versus Dynamic Conditions

Testing may be conducted "as built" (with equipment installed but not operating), "at rest" (equipment running but no personnel present), or "in operation" (normal production with personnel and processes active). GMP qualification typically requires both at-rest and in-operation results, since dynamic conditions represent worst-case particle generation during actual manufacturing.

Testing Samples

Cleanroom and Clean Zone Air

Air is sampled from production rooms, filling rooms, airlocks, gowning areas, and material transfer zones to verify room classification at defined working heights, typically 0.8 m to 1.5 m above floor level and at critical work surfaces.

Aseptic Processing and Critical Zones

Samples are taken at the point of exposure—such as vial filling nozzles, stopper bowls, lyophilizer loading areas, and semi-stoppered vial transport paths—where product is directly vulnerable to airborne contamination.

RABS, Isolators, and Laminar Flow Units

Unidirectional airflow enclosures, biosafety cabinets, and barrier systems are tested to confirm that the protected zone maintains the required ISO Class 5 or Grade A conditions under both static and dynamic states.

Support Areas and HVAC Verification Samples

Air from Grade B, C, and D background areas, as well as supply air downstream of terminal HEPA filters, may be sampled during commissioning, requalification, or filter integrity investigations.

Testing Items

Depending on the purpose of the assessment, the following measurements are typically performed:

  • Total non-viable particle concentration at threshold sizes of 0.3 μm, 0.5 μm, and 5.0 μm (expressed as particles/m³)
  • Cleanroom classification verification against the target ISO Class or GMP Grade
  • At-rest (static) versus in-operation (dynamic) comparison studies
  • Time-averaged or sequential monitoring data for critical production zones
  • Requalification testing following facility modification, filter replacement, or periodical re-certification
  • Deviation investigation support after environmental excursions or contamination events

Non-viable particle testing is normally paired with viable environmental monitoring (settle plates, active air samplers, and contact plates) to provide a complete picture of environmental control.

Testing Methods

Light Scattering Airborne Particle Counter (LSAPC) Method

The standard method follows ISO 14644-1:2015 using a calibrated light scattering airborne particle counter. The instrument draws a known volume of air through a sensing zone; particles scatter light onto a photodetector, and pulse height analysis converts scattering intensity into particle size and count. Results are reported as cumulative counts per cubic meter at each threshold size.

Determination of Sampling Locations and Sample Volume

The minimum number of sampling locations is calculated as the square root of the cleanroom area in square meters, rounded up. Locations are distributed evenly across the room, with sampling probes positioned at working height and oriented appropriately; in unidirectional airflow, isokinetic sampling heads are used to avoid sampling distortion. The minimum air volume per sample is derived from the class limit such that at least 20 particles would be expected at the limit concentration, and each sample lasts at least one minute.

Instrument Calibration and Performance Requirements

Particle counters must be calibrated and verified in accordance with ISO 21501-4, covering sizing accuracy, counting efficiency, flow rate, and false-count rate. Daily zero-count checks with a filtered probe and documented instrument traceability are standard prerequisites before classification testing.

Data Evaluation and Acceptance Criteria

Under ISO 14644-1:2015, each individual sampling location must meet the class limit for the declared particle sizes, and the average of replicate samples at each location must also comply; the former 95% upper confidence limit calculation was removed in this edition. A room passes classification only when all locations satisfy the limits under the declared occupancy state.

Reporting

A compliant test report identifies the tested areas, occupancy state, target class or grade, instrument details and calibration status, sampling map, individual and average counts per location, and a clear pass/fail conclusion against the acceptance criteria.

Applications

Airborne particle detection in pharmaceutical workshops supports the following scenarios:

  • Aseptic processing of sterile injectables, pre-filled syringes, and ophthalmic products requiring Grade A/ISO Class 5 conditions
  • Terminally sterilized product manufacturing with Grade C and D background areas
  • Sterile active pharmaceutical ingredient (API) production and biologics facilities, including vaccine and cell therapy cleanrooms
  • Lyophilization loading and unloading operations under unidirectional airflow protection
  • Cleanroom commissioning, periodic requalification, and post-modification re-certification for HVAC systems and HEPA-filtered zones
  • Investigation of environmental monitoring deviations, media fill failures, and sterility assurance issues
  • Hospital sterile compounding pharmacies and medical device cleanrooms requiring documented air cleanliness evidence
  • Third-party verification during regulatory inspections, new product registration, and technology transfer between sites

Accredited third-party laboratories are frequently engaged to perform this testing, providing independent, traceable reports that satisfy inspectors from agencies such as the FDA, EMA, and NMPA.

FAQ

How often must airborne particle testing be performed?

ISO 14644-2 recommends maximum reclassification intervals of 6 months for cleanrooms of ISO Class 5 or cleaner and 12 months for ISO Classes 6–8. EU GMP and company quality systems may impose stricter schedules, and critical Grade A zones used in aseptic processing are typically monitored continuously or during every batch.

What is the difference between non-viable and viable particle testing?

Non-viable (suspended) particle testing counts all inert airborne particulates using an optical particle counter, providing a rapid real-time indication of air cleanliness and filtration performance. Viable testing captures and cultivates airborne microorganisms. The two methods are complementary: a rise in large non-viable particles often signals an increased microbial contamination risk.

Why do results differ between at-rest and in-operation states?

Personnel are the dominant source of particles in most cleanrooms. In-operation counts are naturally higher due to gowning movement, equipment operation, and material handling. A room that passes at rest but fails in operation indicates excessive personnel-generated contamination or inadequate airflow recovery, and requires corrective actions such as retraining, slower movements, or airflow rebalancing.

What are common causes of out-of-limit particle counts?

Frequent root causes include HEPA filter leaks or damaged gaskets, inadequate air change rates, poor differential pressure control, improper gowning, excessive personnel activity, dirty equipment or surfaces, and faulty sampling technique such as a misoriented probe or an unverified counter.

Can testing be performed during production?

Yes. In fact, GMP requires classification and monitoring under dynamic (in-operation) conditions to demonstrate real manufacturing performance. Sampling must be positioned so that it does not interfere with product protection and does not itself generate contamination.

Which standards should the test report reference?

Reports should reference the applicable edition of ISO 14644-1 for classification methodology, ISO 21501-4 for instrument calibration traceability, ISO 14644-2 for monitoring programs, and EU GMP Annex 1 or equivalent national GMP requirements when the facility manufactures sterile medicinal products.